C
Calidi Biotherapeutics Inc
AMEX:CLDI
Calidi Biotherapeutics Inc
AMEX:CLDI
Price:
0.2164
USD
-8.69%
Market Closed
Market Cap:
$2.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Calidi Biotherapeutics Inc
AMEX:CLDI
|
US |
Income Statement
Earnings Waterfall
Calidi Biotherapeutics Inc
Calidi Biotherapeutics Inc
Income Statement
Calidi Biotherapeutics Inc
Calidi Biotherapeutics Inc
Currency: USD
| Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(22)
|
(29)
|
(31)
|
(30)
|
(28)
|
(22)
|
(20)
|
(20)
|
(20)
|
(20)
|
|
| Selling, General & Administrative |
(13)
|
(16)
|
(17)
|
(17)
|
(17)
|
(13)
|
(12)
|
(11)
|
(11)
|
(11)
|
|
| R&D |
(9)
|
(13)
|
(13)
|
(12)
|
(11)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
|
| Operating Income |
(22)
N/A
|
(29)
-32%
|
(31)
-6%
|
(30)
+2%
|
(28)
+8%
|
(22)
+21%
|
(20)
+8%
|
(20)
+1%
|
(20)
+1%
|
(20)
-2%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
|
| Non-Recurring Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
1
|
2
|
8
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(23)
N/A
|
(29)
-25%
|
(30)
-3%
|
(23)
+22%
|
(26)
-13%
|
(22)
+16%
|
(20)
+10%
|
(20)
+0%
|
(20)
-1%
|
(20)
+0%
|
|
| Net Income | |||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(24)
|
(29)
|
(30)
|
(23)
|
(26)
|
(22)
|
(20)
|
(20)
|
(20)
|
(20)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income |
(24)
N/A
|
(29)
-24%
|
(30)
-3%
|
(25)
+17%
|
(28)
-12%
|
(24)
+15%
|
(22)
+9%
|
(20)
+8%
|
(26)
-29%
|
(26)
+0%
|
|
| EPS (Diluted) |
-62.24
N/A
|
-65.49
-5%
|
-101.19
-55%
|
-56.11
+45%
|
-42.86
+24%
|
-18.69
+56%
|
-9.55
+49%
|
-6.9
+28%
|
-5.22
+24%
|
-3.59
+31%
|
|
Switch to:
Switch to:
See Also
Discover More
